BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32844715)

  • 1. Development of High-Throughput Assays for Evaluation of Hematopoietic Progenitor Kinase 1 Inhibitors.
    Lacey BM; Xu Z; Chai X; Laskey J; Fradera X; Mittal P; Mishra S; Piesvaux J; Saradjian P; Shaffer L; Vassileva G; Gerdt C; Wang Y; Ferguson H; Smith DM; Ballard J; Wells S; Jain R; Mueller U; Addona G; Kariv I; Methot JL; Bittinger M; Ranganath S; Mcleod R; Pasternak A; Miller JR; Xu H
    SLAS Discov; 2021 Jan; 26(1):88-99. PubMed ID: 32844715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of an Allosteric, Inactive Conformation-Selective Inhibitor of Full-Length HPK1 Utilizing a Kinase Cascade Assay.
    Wang W; Mevellec L; Liu A; Struble G; Miller R; Allen SJ; Federowicz K; Wroblowski B; Vialard J; Ahn K; Krosky D
    Biochemistry; 2021 Oct; 60(41):3114-3124. PubMed ID: 34608799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of diaminotriazine carboxamides as potent inhibitors of hematopoetic progenitor kinase 1.
    Zhou L; Ye X; Wang K; Shen H; Wang T; Zhang X; Jiang S; Xiao Y; Zhang K
    Bioorg Chem; 2023 Sep; 138():106682. PubMed ID: 37339563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological inhibition of hematopoietic progenitor kinase 1 positively regulates T-cell function.
    Wang Y; Zhang K; Georgiev P; Wells S; Xu H; Lacey BM; Xu Z; Laskey J; Mcleod R; Methot JL; Bittinger M; Pasternak A; Ranganath S
    PLoS One; 2020; 15(12):e0243145. PubMed ID: 33270695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adaptor protein Gads (Grb2-related adaptor downstream of Shc) is implicated in coupling hemopoietic progenitor kinase-1 to the activated TCR.
    Liu SK; Smith CA; Arnold R; Kiefer F; McGlade CJ
    J Immunol; 2000 Aug; 165(3):1417-26. PubMed ID: 10903746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HPK1 Inhibitor A-745 Verifies the Potential of Modulating T Cell Kinase Signaling for Immunotherapy.
    Malchow S; Korepanova A; Panchal SC; McClure RA; Longenecker KL; Qiu W; Zhao H; Cheng M; Guo J; Klinge KL; Trusk P; Pratt SD; Li T; Kurnick MD; Duan L; Shoemaker AR; Gopalakrishnan SM; Warder SE; Shotwell JB; Lai A; Sun C; Osuma AT; Pappano WN
    ACS Chem Biol; 2022 Mar; 17(3):556-566. PubMed ID: 35188729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor.
    You D; Hillerman S; Locke G; Chaudhry C; Stromko C; Murtaza A; Fan Y; Koenitzer J; Chen Y; Briceno S; Bhadra R; Duperret E; Gullo-Brown J; Gao C; Zhao D; Feder J; Curtin J; Degnan AP; Kumi G; Wittman M; Johnson BM; Parrish KE; Gokulrangan G; Morrison J; Quigley M; Hunt JT; Salter-Cid L; Lees E; Sanjuan MA; Liu J
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33408094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of potent and selective HPK1 inhibitors based on the 2,4-disubstituted pyrimidine scaffold with immune modulatory properties for ameliorating T cell exhaustion.
    Zeng S; Zeng M; Yuan S; He L; Jin Y; Huang J; Zhang M; Yang M; Pan Y; Wang Z; Chen Y; Xu X; Huang W
    Bioorg Chem; 2023 Oct; 139():106728. PubMed ID: 37536217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a mechanism-based high-throughput screen assay for leucine-rich repeat kinase 2--discovery of LRRK2 inhibitors.
    Liu M; Poulose S; Schuman E; Zaitsev AD; Dobson B; Auerbach K; Seyb K; Cuny GD; Glicksman MA; Stein RL; Yue Z
    Anal Biochem; 2010 Sep; 404(2):186-92. PubMed ID: 20566370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic progenitor kinase 1 associates physically and functionally with the adaptor proteins B cell linker protein and SLP-76 in lymphocytes.
    Sauer K; Liou J; Singh SB; Yablonski D; Weiss A; Perlmutter RM
    J Biol Chem; 2001 Nov; 276(48):45207-16. PubMed ID: 11487585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAP4K Family Kinases in Immunity and Inflammation.
    Chuang HC; Wang X; Tan TH
    Adv Immunol; 2016; 129():277-314. PubMed ID: 26791862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using yeast surface display to engineer a soluble and crystallizable construct of hematopoietic progenitor kinase 1 (HPK1).
    Lau WL; Pearce B; Malakian H; Rodrigo I; Xie D; Gao M; Marsilio F; Chang C; Ruzanov M; Muckelbauer JK; Newitt JA; Lipovšek D; Sheriff S
    Acta Crystallogr F Struct Biol Commun; 2021 Jan; 77(Pt 1):22-28. PubMed ID: 33439152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of high-throughput TR-FRET and AlphaScreen assays for identification of potent inhibitors of PDK1.
    Xu Z; Nagashima K; Sun D; Rush T; Northrup A; Andersen JN; Kariv I; Bobkova EV
    J Biomol Screen; 2009 Dec; 14(10):1257-62. PubMed ID: 19822882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interactions between MAP4K1 and adaptor proteins].
    Zhang Q; Zhang H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 40(3):326-35. PubMed ID: 25832533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current strategies for targeting HPK1 in cancer and the barriers to preclinical progress.
    Chen H; Guan X; He C; Lu T; Lin X; Liao X
    Expert Opin Ther Targets; 2024 Apr; 28(4):237-250. PubMed ID: 38650383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of quinazoline HPK1 inhibitors with high cellular potency.
    Toure M; Johnson T; Li B; Schmidt R; Ma H; Neagu C; Lopez AU; Wang Y; Guler S; Xiao Y; Henkes R; Ho K; Zhang S; Chu CL; Gundra UM; Porichis F; Li L; Maurer CK; Fang Z; Musil D; DiPoto M; Friis E; Jones R; Jones C; Cummings J; Chekler E; Tanzer EM; Huck B; Sherer B
    Bioorg Med Chem; 2023 Sep; 92():117423. PubMed ID: 37531921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel src homology 3 domain-containing adaptor protein, HIP-55, that interacts with hematopoietic progenitor kinase 1.
    Ensenat D; Yao Z; Wang XS; Kori R; Zhou G; Lee SC; Tan TH
    J Biol Chem; 1999 Nov; 274(48):33945-50. PubMed ID: 10567356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPK1 competes with ADAP for SLP-76 binding and via Rap1 negatively affects T-cell adhesion.
    Patzak IM; Königsberger S; Suzuki A; Mak TW; Kiefer F
    Eur J Immunol; 2010 Nov; 40(11):3220-5. PubMed ID: 20957749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte-specific adaptor protein Grap2 interacts with hematopoietic progenitor kinase 1 (HPK1) to activate JNK signaling pathway in T lymphocytes.
    Ma W; Xia C; Ling P; Qiu M; Luo Y; Tan TH; Liu M
    Oncogene; 2001 Mar; 20(14):1703-14. PubMed ID: 11313918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of hematopoietic progenitor kinase 1 involves relocation, autophosphorylation, and transphosphorylation by protein kinase D1.
    Arnold R; Patzak IM; Neuhaus B; Vancauwenbergh S; Veillette A; Van Lint J; Kiefer F
    Mol Cell Biol; 2005 Mar; 25(6):2364-83. PubMed ID: 15743830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.